Search results
FDA approves vaccine to prevent infection with the chikungunya virus
United Press International via Yahoo News· 6 months agoThe single-dose shot, known as Ixchiq, is approved for adults who are at increased risk of exposure...
FDA approves first vaccine against chikungunya virus for people over 18
USA TODAY via Yahoo News· 6 months agoThe U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya...
Valneva’s chikungunya vaccine approved by FDA
BioPharma Dive via Yahoo Finance· 6 months agoThe Food and Drug Administration on Thursday cleared drugmaker Valneva's preventive chikungunya virus vaccine in adults, the first shot to prevent...
FDA approves world's 1st chikungunya vaccine
Live Science via Yahoo News· 6 months agoFemale mosquitoes in the species Aedes aegypti (pictured) can carry chikungunya virus and spread it to people. (Image credit: Centers for Disease Control...
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial...
Benzinga via Yahoo Finance· 11 months agoBavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical...
Valneva sells chikungunya vaccine priority review voucher for $103 million
Reuters via AOL· 4 months agoValneva was awarded a tropical disease PRV in November 2023 after it developed Ixchiq, its...
Valneva: "on track" with Chikungunya vaccine after positive data
Reuters via Yahoo News· 1 year agoPARIS (Reuters) - Vaccines company Valneva on Monday reported positive 12-month antibody persistence...
FDA approves world’s first vaccine for ’emerging global health threat’: ‘Prevention of a potentially...
The Cool Down via Yahoo News· 6 months agoEarlier this month, the U.S. Food and Drug Administration (FDA) approved Ixchiq, the world’s first...
FDA approves first vaccine for mosquito-born viral disease
The Hill via Yahoo News· 6 months agoThe Food and Drug Adminstration (FDA) approved the first vaccine for the mosquito-born illness...
Valneva sells regulatory ‘fast pass’ for $103M
BioPharma Dive via Yahoo Finance· 4 months agoVaccine maker Valneva on Monday said it has sold a priority review voucher to an undisclosed buyer for $103 million. The voucher, a sort of regulatory...
